# Philip Radovic

Philip Radovic, physician (born March 27, 1958) is a professor and pediatric surgeon, who practice in South Orange County, California.

## Career

Provided information don’t give readers any useful and concrete information about medical studies and next academic degrees.

## Research

Radovic served as the lead instructor for the use of AbobotulinumtoxinA in the management of hallux valgus in adult patients. He conducted a randomized and placebo-controlled Phase 2 trial for this treatment. Radovic also led a Phase IIa study on the use of Dysport in hallux abducto valgus (HAV).

## Publications

* In 2003, Radovic co-authored a published study titled "Revisiting Epinephrine in Foot Surgery" in the Journal of the American Podiatric Medical Association. The study explored the benefits of using anesthetics containing epinephrine for foot surgery.
* In 2007, Radovic co-authored a published study that introduced a new modification to the Youngswick procedure, a surgical technique for correcting hallux limitus deformity.
* As a Fellowship Director at SouthWestern Podiatric Sports Medicine, Radovic reviewed a publication titled "Bone Marrow Edema Lesions in the Professional Runner," which was published in the American Journal of Sports Medicine in 2014.
* In 1989, Radovic co-authored a study titled "Volume Injection Adhesiotomy," published in the Journal of the American Podiatric Medical Association, which described a novel approach to treating painful post-surgical adhesions.
* In 1990, Radovic co-authored a manuscript titled "Tarsal Tunnel Syndrome, Comprehensive Review of 87 Cases," published in the Journal of the American Podiatric Medical Association.
* In 1990, Radovic co-authored a manuscript titled "Use of the Subcutaneous Tissue Expander for Delayed Primary Closure of Flaps," published in the Journal of Foot Surgery.
* In 2008, Radovic authored a study titled "Nonsurgical Treatment for Hallux Abducto Valgus with Botulinum Toxin A," published in the Journal of the American Podiatric Medical Association, which described a novel method for treating painful hallux valgus (bunion) deformities using botulinum toxin.
* In 2020, Radovic authored a study titled "Nonsurgical Treatment for Hallux Abducto Valgus with Botulinum Toxin A - An Improvement of the Injection Paradigm," published in the Journal of the American Podiatric Medical Association, which presented an improved approach to treating painful hallux valgus deformities with botulinum toxin.
* In 2020, Radovic authored a study titled "Treatment of "Plantar Fasciitis"/Plantar Heel Pain Syndrome with Botulinum Toxin—A Novel Injection Paradigm Pilot Study" in the journal The Foot. This study described a novel treatment method for heel pain syndrome with various causes.

## Patents

* Radovic, Phillip. (2020). "Methods of Treating Abnormalities of the First metatarsophalangeal joint of the Foot." United States Patent 10,869,914. Filed January 3, 2020, and issued December 22, 2020.
* Radovic, Phillip. (2020). "Methods of Treating Pain Associated with Abnormalities of the First metatarsophalangeal joint of the Foot." United States Patent 10,525,112. Filed November 1, 2018, and issued January 7, 2020.
* Radovic, Phillip. (2018). "Methods of Treating Abnormalities of the First metatarsophalangeal joint of the Foot." United States Patent 10,159,723. Filed March 9, 2018, and issued December 25, 2018.
* Radovic, Phillip. (2020). "Functional Orthotic Support Structure for Footwear." United States Patent 10,667,574. Filed July 1, 2019, and issued June 2, 2020.
* Radovic, Phillip. (2020). "Plantar Heel Pain Syndrome Treatment." United States Patent 10,561,715. Filed November 27, 2018, and issued February 18, 2020.
* Radovic, Phillip. (2007). "Methods of Treating Abnormalities of the First metatarsophalangeal joint of the Foot." United States Patent 7,276,244. Filed February 11, 2005, and issued October 2, 2007.